STX-100 regulatory update

FDA granted Orphan Drug designation for Stromedix's STX-100 to treat idiopathic pulmonary fibrosis (IPF). The company, which licensed humanized mAb against integrin alpha(V)beta(6) from Biogen Idec, ...